Multiple System Atrophy: Clinical Trials

3 trials for Multiple System Atrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Terminated 3
Phase 21Terminated 1

Follow Multiple System Atrophy: new trials by email Literature Review of Multiple System Atrophy trials Research Report on Multiple System Atrophy

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
Droxidopa, Midodrine, Placebo - Autonomic Failure, Pure Autonomic Failure
Phase 1TerminatedVanderbilt University Medical Center342016-09-012026-10-23
Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure
Losartan, Captopril, Placebo - Hypertension, Pure Autonomic Failure
Phase 1TerminatedVanderbilt University122011-03-012018-08-24
Augmenting Effects of L-DOPS With Carbidopa and Entacapone
Droxidopa, Carbidopa, Entacapone - Parkinson Disease, Multiple System Atrophy
Phase 1 / Phase 2TerminatedNational Institute of Neurological Disorders and Stroke (NINDS)142007-10-012014-07-17

Narrower conditions

Parkinson Disease (2)  ·  Pure Autonomic Failure (2)  ·  Autonomic Nervous System Diseases (1)  ·  Hypertension (1)  ·  Hypotension, Orthostatic (1)

Broader conditions

Basal Ganglia Diseases (3)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Movement Disorders (3)  ·  Nervous System Diseases (3)  ·  Neurodegenerative Diseases (3)  ·  Primary Dysautonomias (3)  ·  Synucleinopathies (3)  ·  Autonomic Nervous System Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Parkinsonian Disorders (2)  ·  Vascular Diseases (2)  ·  Hypotension (1)  ·  Orthostatic Intolerance (1)

Interventions

Droxidopa (2)  ·  Captopril (1)  ·  Carbidopa (1)  ·  Losartan (1)  ·  Midodrine (1)  ·  entacapone (1)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  Vanderbilt University (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (3)

Top investigators

Italo Biaggioni, MD (2)  ·  David S Goldstein, M.D. (1)